{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:43Z","timestamp":1787067583811,"version":"build-2736575974"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.arr.2024.102269","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T07:25:00Z","timestamp":1710141900000},"page":"102269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Agmatine as a novel intervention for Alzheimer's disease: Pathological insights and cognitive benefits"],"prefix":"10.1016","volume":"96","author":[{"given":"Raj A.","family":"Katariya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivkumar S.","family":"Sammeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur B.","family":"Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandkishor R.","family":"Kotagale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind J.","family":"Umekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh G.","family":"Taksande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00726-019-02720-7","article-title":"The therapeutic and nutraceutical potential of agmatine, and its enhanced production using Aspergillus oryzae","volume":"52","author":"Akasaka","year":"2020","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00002093-200000001-00008","article-title":"Cell mediators of inflammation in the Alzheimer disease brain","volume":"14","author":"Akiyama","year":"2000","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"8","key":"10.1016\/j.arr.2024.102269_bib3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.foodcont.2006.05.006","article-title":"Putrescine production from agmatine by Lactobacillus hilgardii: effect of phenolic compounds","volume":"18","author":"Alberto","year":"2007","journal-title":"Food Control"},{"issue":"6","key":"10.1016\/j.arr.2024.102269_bib4","doi-asserted-by":"crossref","first-page":"C1411","DOI":"10.1152\/ajpcell.00529.2008","article-title":"The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis","volume":"296","author":"Arndt","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib5","first-page":"263","article-title":"The Alzheimer\u2019s disease clinical spectrum: diagnosis and management","volume":"103","author":"Atri","year":"2019","journal-title":"Med. Clin."},{"issue":"9770","key":"10.1016\/j.arr.2024.102269_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer's disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12551-023-01057-6","article-title":"Mitophagy regulation in aging and neurodegenerative disease","volume":"15","author":"Banarase","year":"2023","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.arr.2024.102269_bib8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11064-018-02712-1","article-title":"Therapeutic effect of agmatine on neurological disease: focus on ion channels and receptors","volume":"44","author":"Barua","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2024.102269_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/med\/9780198566342.003.0005","article-title":"Neurotransmitters and neuromodulators in the central nervous system and cardiovascular regulation","volume":"5","author":"Benarroch","year":"2013","journal-title":"Auton. Fail.: a Textb. Clin. Disord. Auton. Nerv. Syst."},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.neuroscience.2010.05.004","article-title":"Agmatine protects against \u03b2-amyloid 25-35-induced memory impairments in the rat","volume":"169","author":"Bergin","year":"2010","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-49078-0","article-title":"Safety and neurochemical profiles of acute and sub-chronic oral treatment with agmatine sulfate","volume":"9","author":"Bergin","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102269_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105192","article-title":"New perspectives on the basal forebrain cholinergic system in Alzheimer\u2019s disease","author":"Berry","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.arr.2024.102269_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.22270\/jddt.v11i4.4855","article-title":"Agmatine: a potential Neurotherapeutic Agent","volume":"11","author":"Binjhade","year":"2021","journal-title":"J. Drug Deliv. Ther."},{"issue":"6","key":"10.1016\/j.arr.2024.102269_bib14","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2353\/ajpath.2007.070403","article-title":"Induction of tau pathology by intracerebral infusion of amyloid-\u03b2-containing brain extract and by amyloid-\u03b2 deposition in APP\u00d7 Tau transgenic mice","volume":"171","author":"Bolmont","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.arr.2024.102269_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0168-1605(00)00526-2","article-title":"Amino acid-decarboxylase activity of bacteria isolated from fermented pork sausages","volume":"66","author":"Bover-Cid","year":"2001","journal-title":"Int. J. Food Microbiol."},{"issue":"24","key":"10.1016\/j.arr.2024.102269_bib16","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer\u2019s disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.arr.2024.102269_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1750-3639.2004.tb00087.x","article-title":"Amyloid \u03b2-Peptide (1-42) Contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain","volume":"14","author":"Butterfield","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2024.102269_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/2470547019858083","article-title":"Novel targets for fast antidepressant responses: possible role of endogenous neuromodulators","volume":"3","author":"Camargo","year":"2019","journal-title":"Chronic Stress"},{"issue":"6","key":"10.1016\/j.arr.2024.102269_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jalz.2009.09.003","article-title":"Everyday technologies for Alzheimer's disease care: research findings, directions, and challenges","volume":"5","author":"Carrillo","year":"2009","journal-title":"Alzheimer'S. Dement."},{"issue":"7","key":"10.1016\/j.arr.2024.102269_bib20","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3390\/biomedicines10071756","article-title":"The involvement of polyamines catabolism in the crosstalk between neurons and astrocytes in neurodegeneration","volume":"10","author":"Cervelli","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2024.102269_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.vph.2016.11.008","article-title":"The blood-brain barrier in Alzheimer\u2019s disease","volume":"89","author":"Chakraborty","year":"2017","journal-title":"Vasc. Pharmacol."},{"issue":"9","key":"10.1016\/j.arr.2024.102269_bib22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-2007-12208","article-title":"Amyloid-\u03b2-induced mitochondrial dysfunction","volume":"12","author":"Chen","year":"2007","journal-title":"J. Alzheimer'S. Dis."},{"issue":"3","key":"10.1016\/j.arr.2024.102269_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/jpet.123.001828","article-title":"Biodistribution of Agmatine to Brain and Spinal Cord after Systemic Delivery","volume":"387","author":"Clements","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.arr.2024.102269_bib25","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s12035-020-01926-1","article-title":"The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"57","author":"Compagnoni","year":"2020","journal-title":"Mol. neurobiol."},{"issue":"10","key":"10.1016\/j.arr.2024.102269_bib26","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.neurobiolaging.2004.01.006","article-title":"Aminopyridazines inhibit \u03b2-amyloid-induced glial activation and neuronal damage in vivo","volume":"25","author":"Craft","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neurobiolaging.2005.08.021","article-title":"Insulin resistance syndrome and Alzheimer's disease: age-and obesity-related effects on memory, amyloid, and inflammation","volume":"26","author":"Craft","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102269_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/B978-0-12-804281-6.00011-2","article-title":"Executive functions","volume":"163","author":"Cristofori","year":"2019","journal-title":"Handb. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.arr.2024.102269_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/acn3.166","article-title":"A practical algorithm for managing Alzheimer's disease: what, when, and why?","volume":"2","author":"Cummings","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"21","key":"10.1016\/j.arr.2024.102269_bib30","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.3390\/ijms222111677","article-title":"Glutamate and GABA in microglia-neuron cross-talk in Alzheimer\u2019s disease","volume":"22","author":"Czapski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.arr.2024.102269_bib31","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s10571-023-01408-7","article-title":"Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer\u2019s Disease: Recent Trends and Future Development","volume":"43","author":"Dave","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.arr.2024.102269_bib32","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/cells10081884","article-title":"Role of Nrf2 in synaptic plasticity and memory in Alzheimer\u2019s disease","volume":"10","author":"Davies","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.arr.2024.102269_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbr.2018.06.032","article-title":"Agmatine attenuates depressive-like behavior and hippocampal oxidative stress following amyloid \u03b2 (A\u03b21-40) administration in mice","volume":"353","author":"de Souza","year":"2018","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.arr.2024.102269_bib34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3233\/JAD-150692","article-title":"Timely diagnosis for Alzheimer\u2019s disease: a literature review on benefits and challenges","volume":"49","author":"Dubois","year":"2016","journal-title":"J. Alzheimer'S. Dis."},{"issue":"3","key":"10.1016\/j.arr.2024.102269_bib35","first-page":"138","article-title":"Burden assessment and quality of life among caregivers for Alzheimer\u2019s patients","volume":"9","author":"Elagamey","year":"2022","journal-title":"Port. Said Sci. J. Nurs."},{"key":"10.1016\/j.arr.2024.102269_bib36","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00210-016-1284-9","article-title":"Agmatine protects rat liver from nicotine-induced hepatic damage via antioxidative, antiapoptotic, and antifibrotic pathways","volume":"389","author":"El-Sherbeeny","year":"2016","journal-title":"Naunyn-Schmiede 'S. Arch. Pharmacol."},{"issue":"19","key":"10.1016\/j.arr.2024.102269_bib37","doi-asserted-by":"crossref","first-page":"10584","DOI":"10.1073\/pnas.97.19.10584","article-title":"Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury","volume":"97","author":"Fairbanks","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.arr.2024.102269_bib38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.molmed.2019.05.013","article-title":"Assessing neuroprotective agents for A\u03b2-induced neurotoxicity","volume":"25","author":"Forest","year":"2019","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3233\/JAD-150520","article-title":"Linguistic features identify Alzheimer\u2019s disease in narrative speech","volume":"49","author":"Fraser","year":"2016","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102269_bib40","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1007\/s12035-015-9182-6","article-title":"Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice","volume":"53","author":"Freitas","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102269_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fmicb.2012.00199","article-title":"Focused review: agmatine in fermented foods","volume":"3","author":"Galgano","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.arr.2024.102269_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fnagi.2018.00437","article-title":"Executive functions in Alzheimer disease: a systematic review","volume":"10","author":"Guarino","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102269_bib43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.phrs.2016.03.023","article-title":"Modulation of learning and memory by natural polyamines","volume":"112","author":"Guerra","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2024.102269_bib44","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","article-title":"Agmatine: metabolic pathway and spectrum of activity in brain","volume":"21","author":"Halaris","year":"2007","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.0000000000006745","article-title":"Translating the biology of aging into novel therapeutics for Alzheimer disease","volume":"92","author":"Hara","year":"2019","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.arr.2024.102269_bib46","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4103\/1673-5374.194803","article-title":"The Epigenome as a therapeutic target for Parkinson's disease","volume":"11","author":"Hegarty","year":"2016","journal-title":"Neural Regen. Res."},{"issue":"11","key":"10.1016\/j.arr.2024.102269_bib47","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011585","article-title":"Alzheimer disease in 2020","volume":"2","author":"Holtzman","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11033-018-4501-4","article-title":"The neuroprotective effect of agmatine against amyloid \u03b2-induced apoptosis in primary cultured hippocampal cells involving ERK, Akt\/GSK-3\u03b2, and TNF-\u03b1","volume":"46","author":"Hooshmandi","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.arr.2024.102269_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1153918","article-title":"Research progress on vestibular dysfunction and visual\u2013spatial cognition in patients with Alzheimer\u2019s disease","volume":"15","author":"Huang","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-12-80","article-title":"Everyday episodic memory in amnestic mild cognitive impairment: a preliminary investigation","volume":"12","author":"Irish","year":"2011","journal-title":"BMC Neurosci."},{"issue":"9","key":"10.1016\/j.arr.2024.102269_bib51","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/gps.4965","article-title":"Bidirectional relationship between caregiver burden and neuropsychiatric symptoms in patients with Alzheimer's disease: a narrative review","volume":"34","author":"Isik","year":"2019","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2024.102269_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmcm.2021.100030","article-title":"Phytotherapy: a promising approach for the treatment of Alzheimer's disease","volume":"2","author":"John","year":"2022","journal-title":"Pharmacol. Res. -Mod. Chin. Med."},{"issue":"5","key":"10.1016\/j.arr.2024.102269_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrn2808","article-title":"Traumatic brain injury and amyloid-\u03b2 pathology: a link to Alzheimer's disease?","volume":"11","author":"Johnson","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-023-01155-w","article-title":"The neuroimmune axis of Alzheimer\u2019s disease","volume":"15","author":"Jorfi","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.arr.2024.102269_bib55","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuropharm.2016.10.029","article-title":"Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling","volume":"113","author":"Kang","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2024.102269_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2011.05.2223","article-title":"P4-200: Agmatine prevents scopolamine-induced impairment in water maze performance","volume":"7","author":"Khales","year":"2011","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.arr.2024.102269_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-021-02109-w","article-title":"Behavioral and psychological symptoms of dementia in patients with Alzheimer\u2019s disease and family caregiver burden: a path analysis","volume":"21","author":"Kim","year":"2021","journal-title":"BMC Geriatr."},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib58","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.expneurol.2004.05.029","article-title":"Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury","volume":"189","author":"Kim","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102269_bib59","doi-asserted-by":"crossref","DOI":"10.4045\/tidsskr.20.0919","article-title":"Alzheimers sykdom\u2013diagnostikk og behandling","author":"Knapskog","year":"2021","journal-title":"Tidsskr. Den. Nor. legeforening"},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5115\/acb.21.089","article-title":"Role of agmatine in the application of neural progenitor cell in central nervous system diseases: therapeutic potentials and effects","volume":"54","author":"Kosonen","year":"2021","journal-title":"Anat. Cell Biol."},{"key":"10.1016\/j.arr.2024.102269_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172976","article-title":"Agmatine reverses memory deficits induced by A\u03b21\u201342 peptide in mice: a key role of imidazoline receptors","volume":"196","author":"Kotagale","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.arr.2024.102269_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2020.06.002","article-title":"Involvement of hippocampal agmatine in \u03b21-42 amyloid induced memory impairment, neuroinflammation and BDNF signaling disruption in mice","volume":"80","author":"Kotagale","year":"2020","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.arr.2024.102269_bib63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuro.2019.05.001","article-title":"Neuroprotective offerings by agmatine","volume":"73","author":"Kotagale","year":"2019","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib64","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuron.2008.06.008","article-title":"A\u03b2 plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks","volume":"59","author":"Kuchibhotla","year":"2008","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt155","article-title":"Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome","volume":"5","author":"Lam","year":"2013","journal-title":"Alzheimer'S. Res. Ther."},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"15","key":"10.1016\/j.arr.2024.102269_bib67","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1042\/BCJ20170007","article-title":"Agmatine: multifunctional arginine metabolite and magic bullet in clinical neuroscience?","volume":"474","author":"Laube","year":"2017","journal-title":"Biochem. J."},{"issue":"9","key":"10.1016\/j.arr.2024.102269_bib68","first-page":"823","article-title":"The research progress of relationship between the Alzheimer\u2019s disease and outside the synapses, and synaptic NMDA receptor","volume":"41","author":"Li","year":"2014","journal-title":"Prog. Biochem. Biophys."},{"issue":"9","key":"10.1016\/j.arr.2024.102269_bib69","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/hipo.20448","article-title":"Effects of aging on agmatine levels in memory\u2010associated brain structures","volume":"18","author":"Liu","year":"2008","journal-title":"Hippocampus"},{"issue":"3","key":"10.1016\/j.arr.2024.102269_bib70","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2012-120901","article-title":"Visuospatial perception: an emerging biomarker for Alzheimer's disease","volume":"31","author":"Mandal","year":"2012","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102269_bib71","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbr.2012.08.017","article-title":"Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)","volume":"235","author":"Matheus","year":"2012","journal-title":"Behav. brain Res."},{"key":"10.1016\/j.arr.2024.102269_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00467-y","article-title":"The informed road map to prevention of Alzheimer Disease: a call to arms","volume":"16","author":"McDade","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1567205018666211029164106","article-title":"Astrocyte reactivity in Alzheimer's disease: therapeutic opportunities to promote repair","volume":"19","author":"Mirzaei","year":"2022","journal-title":"Curr. Alzheimer Res."},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2019.0377","article-title":"Global ageing: successes, challenges and opportunities","volume":"81","author":"Mitchell","year":"2020","journal-title":"Br. J. Hosp. Med."},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib75","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2741\/710","article-title":"Role of agmatine in neurodegenerative diseases and epilepsy","volume":"6","author":"Moretti","year":"2014","journal-title":"Front. Biosci. -Elite"},{"issue":"3","key":"10.1016\/j.arr.2024.102269_bib76","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.58.3.397","article-title":"Mild cognitive impairment represents early-stage Alzheimer disease","volume":"58","author":"Morris","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2024.102269_bib77","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer's disease: the prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102269_bib78","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.neuint.2017.05.006","article-title":"Therapeutic potential of agmatine for CNS disorders","volume":"108","author":"Neis","year":"2017","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.arr.2024.102269_bib79","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.euroneuro.2016.03.009","article-title":"Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling","volume":"26","author":"Neis","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib80","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jalz.2016.09.014","article-title":"Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic","volume":"13","author":"O'Bryant","year":"2017","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.arr.2024.102269_bib81","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12602-017-9262-1","article-title":"Role of neurochemicals in the interaction between the microbiota and the immune and the nervous system of the host organism","volume":"9","author":"Oleskin","year":"2017","journal-title":"Probiotics Antimicrob. Proteins"},{"issue":"17-18","key":"10.1016\/j.arr.2024.102269_bib82","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","article-title":"Agmatine: clinical applications after 100 years in translation","volume":"18","author":"Piletz","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.arr.2024.102269_bib83","first-page":"371","article-title":"Diagnosis of early Alzheimer\u2019s disease: clinical practice in 2021","volume":"8","author":"Porsteinsson","year":"2021","journal-title":"J. Prev. Alzheimer'S. Dis."},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib84","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"Qiu","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"issue":"26","key":"10.1016\/j.arr.2024.102269_bib85","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/0024-3205(95)00226-V","article-title":"Agmatine, the bacterial amine, is widely distributed in mammalian tissues","volume":"56","author":"Raasch","year":"1995","journal-title":"Life sci."},{"issue":"6","key":"10.1016\/j.arr.2024.102269_bib86","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.bjp.0704153","article-title":"Biological significance of agmatine, an endogenous ligand at imidazoline binding sites","volume":"133","author":"Raasch","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.arr.2024.102269_bib87","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.phrs.2003.10.008","article-title":"Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine","volume":"49","author":"Raghavan","year":"2004","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.arr.2024.102269_bib88","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/cells8050488","article-title":"Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer\u2019s disease","volume":"8","author":"Reddy","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.arr.2024.102269_bib89","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.arr.2013.06.004","article-title":"Frailty and cognitive impairment\u2014a review of the evidence and causal mechanisms","volume":"12","author":"Robertson","year":"2013","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369101","article-title":"Amyloid-beta: a crucial factor in Alzheimer's disease","volume":"24","author":"Sadigh-Eteghad","year":"2015","journal-title":"Med. Princ. Pract."},{"issue":"21","key":"10.1016\/j.arr.2024.102269_bib91","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.3390\/ijms232112924","article-title":"Amyloid beta in aging and Alzheimer\u2019s disease","volume":"23","author":"Sehar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102269_bib92","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.biopha.2017.05.085","article-title":"Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals","volume":"92","author":"Singh","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"13-14","key":"10.1016\/j.arr.2024.102269_bib93","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.lfs.2011.07.003","article-title":"Agmatine enhances neurogenesis by increasing ERK1\/2 expression, and suppresses astrogenesis by decreasing BMP 2, 4 and SMAD 1, 5, 8 expression in subventricular zone neural stem cells","volume":"89","author":"Song","year":"2011","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.arr.2024.102269_bib94","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3349\/ymj.2014.55.3.689","article-title":"Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model","volume":"55","author":"Song","year":"2014","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.arr.2024.102269_bib95","first-page":"2012","article-title":"New insights in the amyloid-Beta interaction with mitochondria","author":"Spuch","year":"2012","journal-title":"J. Aging Res."},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib96","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","article-title":"Alzheimer\u2019s disease: epidemiology and clinical progression","volume":"11","author":"Tahami Monfared","year":"2022","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.arr.2024.102269_bib97","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pbb.2015.03.005","article-title":"Agmatine attenuates hyperactivity and weight loss associated with activity-based anorexia in female rats","volume":"132","author":"Taksande","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.arr.2024.102269_bib98","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pbb.2015.02.013","article-title":"Agmatine attenuates lipopolysaccharide-induced anorexia and sickness behavior in rats","volume":"132","author":"Taksande","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.arr.2024.102269_bib99","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006148","article-title":"The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment","volume":"2","author":"Tarawneh","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"8","key":"10.1016\/j.arr.2024.102269_bib100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2174\/1389557043403305","article-title":"Cellular and physiological effects of arginine","volume":"4","author":"Tong","year":"2004","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.arr.2024.102269_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2021.772810","article-title":"Amino acids in plants: regulation and functions in development and stress defense","volume":"12","author":"Trovato","year":"2021","journal-title":"Front. Plant Sci."},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib102","doi-asserted-by":"crossref","first-page":"65","DOI":"10.12991\/201216404","article-title":"Alzheimer disease and neuroplasticity: New approaches and new targets in pharmacotherapy","volume":"16","author":"Uzbay","year":"2012","journal-title":"Marmara Pharm. J."},{"issue":"11","key":"10.1016\/j.arr.2024.102269_bib103","doi-asserted-by":"crossref","first-page":"981","DOI":"10.5498\/wjp.v11.i11.981","article-title":"Agmatine as a novel candidate for rapid-onset antidepressant response","volume":"11","author":"Valverde","year":"2021","journal-title":"World J. Psychiatry"},{"issue":"15","key":"10.1016\/j.arr.2024.102269_bib104","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1111\/bph.15478","article-title":"Disease-modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: a comparative study with donepezil","volume":"178","author":"Vasilopoulou","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.arr.2024.102269_bib105","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1517\/13543784.2015.1048334","article-title":"Investigational sigma-1 receptor antagonists for the treatment of pain","volume":"24","author":"Vela","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"2","key":"10.1016\/j.arr.2024.102269_bib106","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2648.2007.04494.x","article-title":"Quality of life for caregivers of people with Alzheimer\u2019s disease","volume":"61","author":"Vellone","year":"2008","journal-title":"J. Adv. Nurs."},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13601-y","article-title":"Gut microbiome alterations in Alzheimer\u2019s disease","volume":"7","author":"Vogt","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.arr.2024.102269_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.113.114637","article-title":"Arginine decarboxylase and agmatinase: an alternative pathway for de novo biosynthesis of polyamines for development of mammalian conceptuses","volume":"90","author":"Wang","year":"2014","journal-title":"Biol. reprod."},{"issue":"3","key":"10.1016\/j.arr.2024.102269_bib109","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jalz.2009.01.028","article-title":"Early identification and treatment of Alzheimer's disease: social and fiscal outcomes","volume":"5","author":"Weimer","year":"2009","journal-title":"Alzheimer'S. Dement."},{"issue":"4","key":"10.1016\/j.arr.2024.102269_bib110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0301-0082(00)00056-3","article-title":"Arginine metabolism and the synthesis of nitric oxide in the nervous system","volume":"64","author":"Wiesinger","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2012.11.006","article-title":"The worldwide economic impact of dementia 2010","volume":"9","author":"Wimo","year":"2013","journal-title":"Alzheimer\u2019s dement."},{"key":"10.1016\/j.arr.2024.102269_bib112","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1017\/S1041610213000318","article-title":"Aspects of communication in Alzheimer's disease: clinical features and treatment options","volume":"25","author":"Woodward","year":"2013","journal-title":"Int. Psychogeriatr."},{"issue":"9","key":"10.1016\/j.arr.2024.102269_bib113","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.2174\/1570159X15666170808120633","article-title":"Neuroprotective role of agmatine in neurological diseases","volume":"16","author":"Xu","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.arr.2024.102269_bib114","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.3390\/ijms24043841","article-title":"Neurotransmitters in prevention and treatment of Alzheimer\u2019s Disease","volume":"24","author":"Yang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102269_bib115","doi-asserted-by":"crossref","DOI":"10.1177\/09603271221110857","article-title":"Agmatine mitigates palmitate (PA)-induced mitochondrial and metabolic dysfunction in microvascular endothelial cells","volume":"41","author":"Zhang","year":"2022","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.arr.2024.102269_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2023.04.005","article-title":"Gut microbiota and its metabolites: bridge of dietary nutrients and Alzheimer\u2019s disease","author":"Zhu","year":"2023","journal-title":"Adv. Nutr."},{"issue":"1","key":"10.1016\/j.arr.2024.102269_bib117","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/fhep-2014-0013","article-title":"The value of delaying Alzheimer\u2019s disease onset","volume":"18","author":"Zissimopoulos","year":"2015","journal-title":"Forum Health Econ. Policy"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T17:53:11Z","timestamp":1718473991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724000874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":117,"alternative-id":["S1568163724000874"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102269","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agmatine as a novel intervention for Alzheimer's disease: Pathological insights and cognitive benefits","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102269"}}